These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12928047)

  • 21. Relationship between the hs-CRP as non-specific biomarker and Alzheimer's disease according to aging process.
    Song IU; Chung SW; Kim YD; Maeng LS
    Int J Med Sci; 2015; 12(8):613-7. PubMed ID: 26283879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus.
    Bozluolcay M; Andican G; Fırtına S; Erkol G; Konukoglu D
    Geriatr Gerontol Int; 2016 Oct; 16(10):1161-1166. PubMed ID: 26337250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypes.
    Scacchi R; Ruggeri M; Gambina G; Martini MC; Ferrari G; Corbo RM
    Neurobiol Aging; 2001; 22(3):413-6. PubMed ID: 11378247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The plant sterol brassicasterol as additional CSF biomarker in Alzheimer's disease.
    Vanmierlo T; Popp J; Kölsch H; Friedrichs S; Jessen F; Stoffel-Wagner B; Bertsch T; Hartmann T; Maier W; von Bergmann K; Steinbusch H; Mulder M; Lütjohann D
    Acta Psychiatr Scand; 2011 Sep; 124(3):184-92. PubMed ID: 21585343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.
    Villarreal AE; O'Bryant SE; Edwards M; Grajales S; Britton GB;
    Neurodegener Dis Manag; 2016 Jun; 6(3):203-13. PubMed ID: 27229914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
    Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
    Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of plasma alpha 1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls.
    Wang X; DeKosky ST; Ikonomovic MD; Kamboh MI
    Neurobiol Aging; 2002; 23(3):377-82. PubMed ID: 11959399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro-inflammatory cytokines IL-1β and TNF-α are not associated with plasma homocysteine concentration in Alzheimer's disease.
    Veryard L; Jones E; Weaving G; Smith E; Cheek L; Wickramasinghe A; Tabet N
    Curr Alzheimer Res; 2013 Feb; 10(2):174-9. PubMed ID: 23463936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Systemic inflammatory markers in age-associated cognitive impairment and Alzheimer's disease].
    Kliushnik TP; Androsova LV; Mikhaylova NM; Kolykhalov IV; Zozulya SA; Dupin AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):74-79. PubMed ID: 28805765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.
    Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Rao ML; Maier W; Björkhem I; von Bergmann K; Heun R
    Neuroreport; 2000 Jun; 11(9):1959-62. PubMed ID: 10884051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
    Kim YS; Lee KJ; Kim H
    Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
    Solomon A; Leoni V; Kivipelto M; Besga A; Oksengård AR; Julin P; Svensson L; Wahlund LO; Andreasen N; Winblad B; Soininen H; Björkhem I
    Neurosci Lett; 2009 Oct; 462(1):89-93. PubMed ID: 19560513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum noncholesterol sterols in Alzheimer's disease: the Helsinki Businessmen Study.
    Sittiwet C; Simonen P; Nissinen MJ; Gylling H; Strandberg TE
    Transl Res; 2018 Dec; 202():120-128. PubMed ID: 30102918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application value of serum biomarkers for choosing memantine therapy for moderate AD.
    Wei H; Zhu X; Li Y
    J Neurol; 2018 Aug; 265(8):1844-1849. PubMed ID: 29948244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.
    Irizarry MC; Gurol ME; Raju S; Diaz-Arrastia R; Locascio JJ; Tennis M; Hyman BT; Growdon JH; Greenberg SM; Bottiglieri T
    Neurology; 2005 Nov; 65(9):1402-8. PubMed ID: 16275827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological alpha 1-antichymotrypsin in Down's syndrome and Alzheimer's disease.
    Brugge K; Katzman R; Hill LR; Hansen LA; Saitoh T
    Ann Neurol; 1992 Aug; 32(2):193-7. PubMed ID: 1387300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia.
    Matsubara E; Hirai S; Amari M; Shoji M; Yamaguchi H; Okamoto K; Ishiguro K; Harigaya Y; Wakabayashi K
    Ann Neurol; 1990 Oct; 28(4):561-7. PubMed ID: 2147546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease.
    Heafield MT; Fearn S; Steventon GB; Waring RH; Williams AC; Sturman SG
    Neurosci Lett; 1990 Mar; 110(1-2):216-20. PubMed ID: 2325885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. There are no differences in IL-6, CRP and homocystein concentrations between women whose mothers had AD and women whose mothers did not have AD.
    Devčić S; Glamuzina L; Ruljancic N; Mihanovic M
    Psychiatry Res; 2014 Dec; 220(3):970-4. PubMed ID: 25240941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.